K000012

Substantially Equivalent

IMMULITE PHENOBARBITAL, MODELS LKPB1, LKPB5

Applicant: Diagnostic Products Corp.
Product code: DLZ
Advisory panel: Clinical Toxicology
Date received: 2000-01-03
Decision date: 2000-03-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.